Brief: Astellas Pharma Inc - Notice Regarding Impairment Loss And Extraordinary Losses In Non-Consolidated Financial Results(J-GAAP)
27/04/2026 07:40
April 27 (Reuters) - Astellas Pharma Inc 4503.T: ASTELLAS PHARMA INC - NOTICE REGARDING IMPAIRMENT LOSS AND EXTRAORDINARY LOSSES IN NON-CONSOLIDATED FINANCIAL RESULTS(J-GAAP) Source text: ID:nTSpa7cedf Further company coverage: 4503.T
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn